Measuring Quality Attributes for Gene Therapies: Empty vs Full Viral Vector Capsids
Summary: Catalent offers tools to measure the ratio and help assess the safety and efficacy of viral vector-based therapies.
Navigating the Path to the Clinic and Beyond for Gene Therapies
Summary: In this webinar, hear from Catalent panelists as they discuss navigating the path from research lab to the clinic.
Webinar: Are Real-Time Gene Therapy Test Results Possible?
Summary: Radiance® data is presented on rapid and low error adenovirus and baculovirus infectivity measurements as well as AAV transfection monitoring.
Manufacturing Innovation Across New Modalities
Summary: The successful outcomes delivered by cell and gene therapies coupled with emergence of modalities across nucleic acid therapeutics and microbiomes pose the next challenge for innovators to make these new modalities…
Pharma Predictions for 2021
Summary: Catalent CEO John Chiminski to talks about the year ahead, offering projections for what 2021 holds in store for the biopharma industry.
Cell and Gene Therapy Brochure
Summary: Catalent Cell & Gene Therapy is a premier partner for innovators across the entire field of advanced biotherapeutics. Explore our development and manufacturing capabilities for allogeneic and autologous cell therapies, viral vector-based…